{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:50:09Z","timestamp":1794037809598,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Danish Research Council for Independent Research, Technology and Production","award":["12-127417"],"award-info":[{"award-number":["12-127417"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijantimicag.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T15:41:42Z","timestamp":1528818102000},"page":"390-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus"],"prefix":"10.1016","volume":"52","author":[{"given":"Katrine","family":"N\u00f8hr-Meldgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Ovsepian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-5631","authenticated-orcid":false,"given":"Hanne","family":"Ingmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0001","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0924-8579(09)70549-7","article-title":"Antibiotic resistance: the perfect storm","volume":"34","author":"Gould","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ja.2016.72","article-title":"Antibiotics in the clinical pipeline at the end of 2015","volume":"70","author":"Butler","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0003","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.coph.2012.07.005","article-title":"Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance","volume":"12","author":"Pieren","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijmm.2013.02.009","article-title":"Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions","volume":"303","author":"Cox","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0006","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jac\/dkn088","article-title":"Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus","volume":"61","author":"Kumar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0007","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.00906-09","article-title":"Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code","volume":"54","author":"Liu","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0008","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1128\/AAC.00579-06","article-title":"Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi","volume":"50","author":"Gomez","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0009","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.00035-09","article-title":"Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa","volume":"53","author":"D\u00f6tsch","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jac\/dks373","article-title":"Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents","volume":"68","author":"Blake","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0011","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3389\/fmicb.2016.02018","article-title":"Genome-wide identification of antimicrobial intrinsic resistance determinants in Staphylococcus aureus","volume":"7","author":"Vestergaard","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0012","doi-asserted-by":"crossref","first-page":"e01114","DOI":"10.1128\/mBio.01114-17","article-title":"Inhibition of the ATP synthase eliminates the intrinsic resistance of Staphylococcus aureus towards polymyxins","volume":"8","author":"Vestergaard","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0013","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1444-0903.2005.00976.x","article-title":"Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus","volume":"35","author":"Rayner","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0014","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/520991","article-title":"Back to the future: using aminoglycosides again and how to dose them optimally","volume":"45","author":"Eliopoulos","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/MMBR.00016-08","article-title":"ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas","volume":"72","author":"Hong","year":"2008","journal-title":"Microbiol Molec Biol Rev"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0016","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbrc.2003.08.105","article-title":"Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses","volume":"309","author":"Leonard","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0100","first-page":"13632","article-title":"Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols","volume":"104(34)","author":"Gledhill","year":"2007"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijbiomac.2009.04.004","article-title":"Inhibition of ATPase activity of Escherichia coli ATP synthase by polyphenols","volume":"45","author":"Dadi","year":"2009","journal-title":"Int J Biol Macromolec"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0019","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/febs.13715","article-title":"Deletion of a unique loop in the mycobacterial F\u2010ATP synthase \u03b3 subunit sheds light on its inhibitory role in ATP hydrolysis\u2010driven H+ pumping","volume":"283","author":"Hotra","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200900437","article-title":"Resveratrol bioavailability and toxicity in humans","volume":"54","author":"Cottart","year":"2010","journal-title":"Molec Nutr Food Res"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12889-015-1348-7","article-title":"Resveratrol food supplements: a survey on the role of individual consumer characteristics in predicting the attitudes and adoption intentions of US American and Danish respondents","volume":"15","author":"Aschemann-Witzel","year":"2015","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12866-015-0376-x","article-title":"Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide","volume":"15","author":"Stiefel","year":"2015","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0024","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11274-010-0325-7","article-title":"Antimicrobial activity and effects of resveratrol on human pathogenic bacteria","volume":"26","author":"Paulo","year":"2010","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/jac\/dkm099","article-title":"Resveratrol inhibition of Propionibacterium acnes","volume":"59","author":"Docherty","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02977758","article-title":"Fungicidal effect of resveratrol on human infectious fungi","volume":"28","author":"Jung","year":"2005","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01866","article-title":"Novel pathways for ameliorating the fitness cost of gentamicin resistant small colony variants","volume":"7","author":"Vestergaard","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0028","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrmicro1384","article-title":"Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections","volume":"4","author":"Proctor","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0029","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/JB.157.3.863-867.1984","article-title":"Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus","volume":"157","author":"Eisenberg","year":"1984","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.ijantimicag.2018.06.005_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijantimicag.2017.08.024","article-title":"Multiple paths towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus","volume":"51","author":"Vestergaard","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0031","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1038\/srep10029","article-title":"Resveratrol antibacterial activity against Escherichia coli is mediated by Z-ring formation inhibition via suppression of FtsZ expression","volume":"5","author":"Hwang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.redox.2014.06.007","article-title":"Resveratrol induced inhibition of Escherichia coli proceeds via membrane oxidation and independent of diffusible reactive oxygen species generation","volume":"2","author":"Subramanian","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0033","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"Martinez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0034","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7364","article-title":"TarO-specific inhibitors of wall teichoic acid biosynthesis restore \u03b2-lactam efficacy against methicillin-resistant staphylococci","volume":"8","author":"Lee","year":"2016","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/MMBR.51.4.439-457.1987","article-title":"Bacterial uptake of aminoglycoside antibiotics","volume":"51","author":"Taber","year":"1987","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0036","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbabio.2011.10.006","article-title":"Physiology and global gene expression of a Corynebacterium glutamicum \u0394F 1 F o-ATP synthase mutant devoid of oxidative phosphorylation","volume":"1817","author":"Koch-Koerfges","year":"2012","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0037","article-title":"Resveratrol antagonizes antimicrobial lethality and stimulates recovery of bacterial mutants","volume":"11","author":"Liu","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0038","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2018.06.005_bib0039","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/AAC.00273-12","article-title":"Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria","volume":"56","author":"Balemans","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T12:00:47Z","timestamp":1604404847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918301626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0924857918301626"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.06.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}